• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CABG 手术后的二次血运重建。

Secondary revascularization after CABG surgery.

机构信息

Cardiovascular Institute, Hospital Clínico San Carlos, Calle del Profesor Martín Lagos s/n, 28040 Madrid, Spain.

出版信息

Nat Rev Cardiol. 2012 Sep;9(9):540-9. doi: 10.1038/nrcardio.2012.100. Epub 2012 Jul 10.

DOI:10.1038/nrcardio.2012.100
PMID:22776987
Abstract

CABG surgery is an effective way to improve symptoms and prognosis in patients with advanced coronary atherosclerotic disease. Despite multiple improvements in surgical technique and patient treatment, graft failure after CABG surgery occurs in a time-dependent fashion, particularly in the second decade after the intervention, in a substantial number of patients because of atherosclerotic progression and saphenous-vein graft (SVG) disease. Until 2010, repeat revascularization by either percutaneous coronary intervention (PCI) or surgical techniques was performed in these high-risk patients in the absence of specific recommendations in clinical practice guidelines, and within a culture of inadequate communication between cardiac surgeons and interventional cardiologists. Indeed, some of the specific technologies developed to reduce procedural risk, such as embolic protection devices for SVG interventions, are largely underused. Additionally, the implementation of secondary prevention, which reduces the need for reintervention in these patients, is still suboptimal. In this Review, graft failure after CABG surgery is examined as a clinical problem from the perspective of holistic patient management. Issues such as the substrate and epidemiology of graft failure, the choice of revascularization modality, the specific problems inherent in repeat CABG surgery and PCI, and the importance of secondary prevention are discussed.

摘要

CABG 手术是改善晚期冠状动脉粥样硬化性疾病患者症状和预后的有效方法。尽管手术技术和患者治疗有了多项改进,但 CABG 手术后的移植物失败仍以时间依赖的方式发生,尤其是在干预后的第二个十年,相当一部分患者因动脉粥样硬化进展和大隐静脉移植物(SVG)疾病而发生移植物失败。直到 2010 年,在临床实践指南中缺乏具体建议的情况下,这些高危患者要么通过经皮冠状动脉介入治疗(PCI),要么通过外科技术进行再次血运重建,而且心脏外科医生和介入心脏病学家之间的沟通文化也不足。事实上,一些旨在降低手术风险的特定技术,如 SVG 介入的栓塞保护装置,在很大程度上未得到充分利用。此外,减少这些患者再次介入需求的二级预防的实施仍然不尽如人意。在这篇综述中,从整体患者管理的角度,将 CABG 手术后的移植物失败视为一个临床问题进行了探讨。讨论了移植物失败的基质和流行病学、血运重建方式的选择、重复 CABG 手术和 PCI 固有的特定问题以及二级预防的重要性等问题。

相似文献

1
Secondary revascularization after CABG surgery.CABG 手术后的二次血运重建。
Nat Rev Cardiol. 2012 Sep;9(9):540-9. doi: 10.1038/nrcardio.2012.100. Epub 2012 Jul 10.
2
Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies.隐静脉移植物失败:从病理生理学到预防和治疗策略。
Circulation. 2021 Aug 31;144(9):728-745. doi: 10.1161/CIRCULATIONAHA.120.052163. Epub 2021 Aug 30.
3
Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization.当代冠状动脉旁路移植术及后续的经皮血运重建术。
Nat Rev Cardiol. 2022 Mar;19(3):195-208. doi: 10.1038/s41569-021-00612-6. Epub 2021 Oct 5.
4
Repeat revascularization: Percutaneous coronary intervention after coronary artery bypass graft surgery.重复血运重建:冠状动脉旁路移植术后的经皮冠状动脉介入治疗
Cardiovasc Revasc Med. 2016 Jun;17(4):272-8. doi: 10.1016/j.carrev.2016.04.007. Epub 2016 Apr 28.
5
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较:外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
6
Lower Repeat Revascularization Rates Among Patients With Prior Coronary Artery Bypass Graft Surgery are Due to Lack of Adequate Target Vessels.既往接受冠状动脉旁路移植术患者的再次血管重建率较低是由于缺乏足够的靶血管。
J Invasive Cardiol. 2018 Feb;30(2):51-55. Epub 2017 Nov 15.
7
Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial.冠状动脉旁路移植术中使用具有多个与单个远端靶目标的隐静脉移植物:来自经转染的体外静脉移植物工程(PREVENT)IV 试验的一年移植物失败和五年结果。
Circulation. 2011 Jul 19;124(3):280-8. doi: 10.1161/CIRCULATIONAHA.110.991299. Epub 2011 Jun 27.
8
Radial artery vs saphenous vein graft used as the second conduit for surgical myocardial revascularization: long-term clinical follow-up.桡动脉与大隐静脉移植物作为外科心肌血运重建的第二条血管桥:长期临床随访
J Cardiothorac Surg. 2015 Oct 15;10:127. doi: 10.1186/s13019-015-0331-9.
9
Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery.冠状动脉旁路移植术后急性围手术期移植血管失败患者的急诊再血管化治疗,采用经皮冠状动脉介入治疗、再次手术或保守治疗。
Eur J Cardiothorac Surg. 2006 Jul;30(1):117-25. doi: 10.1016/j.ejcts.2006.03.062. Epub 2006 May 24.
10
Relationship between plaque composition by virtual histology intravascular ultrasound and clinical outcomes after percutaneous coronary intervention in saphenous vein graft disease patients: study protocol of a prospective cohort study.基于虚拟组织学血管内超声的斑块成分与经皮冠状动脉介入治疗后静脉桥病变患者临床结局的关系:一项前瞻性队列研究的研究方案。
BMC Cardiovasc Disord. 2018 Dec 12;18(1):233. doi: 10.1186/s12872-018-0975-1.

引用本文的文献

1
Electronic vascular conduit for in situ identification of hemadostenosis and thrombosis in small animals and nonhuman primates.用于原位识别小动物和非人类灵长类动物血管狭窄和血栓形成的电子血管导管。
Nat Commun. 2025 Mar 18;16(1):2671. doi: 10.1038/s41467-025-58056-2.
2
Saphenous Vein Graft Failure: Current Challenges and a Review of the Contemporary Percutaneous Options for Management.大隐静脉移植血管失败:当前挑战及当代经皮治疗选择综述
J Clin Med. 2023 Nov 15;12(22):7118. doi: 10.3390/jcm12227118.
3
For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?-A 5-year follow-up cohort study.

本文引用的文献

1
Dual-Source computed tomography of the chest in the surgical planning of repeated cardiac surgery.双源计算机断层扫描在再次心脏手术外科规划中的胸部应用
J Cardiovasc Surg (Torino). 2012 Apr;53(2):247-55.
2
Use of fractional flow reserve in contemporary scenarios of coronary revascularization.在当代冠状动脉血运重建场景中使用血流储备分数。
Minerva Med. 2011 Oct;102(5):399-415.
3
Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts: incidence, predictors and effect of the type of protection device.经皮冠状动脉介入治疗中静脉桥血管无复流现象的滤过:发生率、预测因素和保护装置类型的影响。
对于既往行冠状动脉旁路移植术和复发性心肌缺血的患者,旁路移植血管或原生冠状动脉的经皮冠状动脉介入治疗如何?一项 5 年随访队列研究。
Clin Cardiol. 2023 Jun;46(6):680-688. doi: 10.1002/clc.24021. Epub 2023 Apr 28.
4
Non-invasive Ischaemia Testing in Patients With Prior Coronary Artery Bypass Graft Surgery: Technical Challenges, Limitations, and Future Directions.既往接受冠状动脉旁路移植术患者的无创缺血检测:技术挑战、局限性及未来方向
Front Cardiovasc Med. 2021 Dec 23;8:795195. doi: 10.3389/fcvm.2021.795195. eCollection 2021.
5
Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization.当代冠状动脉旁路移植术及后续的经皮血运重建术。
Nat Rev Cardiol. 2022 Mar;19(3):195-208. doi: 10.1038/s41569-021-00612-6. Epub 2021 Oct 5.
6
Microarray analysis of the time-dependent expression profiles of long non-coding RNAs in the progression of vein graft stenotic disease.静脉移植狭窄疾病进展过程中长链非编码RNA时间依赖性表达谱的微阵列分析
Exp Ther Med. 2021 Jun;21(6):635. doi: 10.3892/etm.2021.10067. Epub 2021 Apr 15.
7
Coronary Angiography Characteristics of Symptomatic Patients with Prior Coronary Artery Bypass Graft: A Descriptive Study.有症状的冠状动脉旁路移植术患者的冠状动脉造影特征:描述性研究。
Biomed Res Int. 2019 Nov 11;2019:1832128. doi: 10.1155/2019/1832128. eCollection 2019.
8
Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents.既往冠状动脉旁路移植术后患者应用新一代药物洗脱支架的长期预后。
J Am Heart Assoc. 2018 Jan 30;7(3):e007212. doi: 10.1161/JAHA.117.007212.
EuroIntervention. 2011 Dec;7(8):955-61. doi: 10.4244/EIJV7I8A151.
4
Decreasing prevalence but increasing importance of left ventricular dysfunction and reoperative surgery in prediction of mortality in coronary artery bypass surgery: trends over 18 years.在冠状动脉旁路移植手术中,左心室功能障碍和再次手术的发生率下降但重要性增加,预测死亡率的趋势:18 年来的变化。
J Thorac Cardiovasc Surg. 2012 Aug;144(2):340-6, 346.e1. doi: 10.1016/j.jtcvs.2011.06.043. Epub 2011 Nov 20.
5
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.2011年美国心脏病学会基金会/美国心脏协会/心血管造影和介入学会经皮冠状动脉介入治疗指南:美国心脏病学会基金会/美国心脏协会实践指南工作组及心血管造影和介入学会的报告。
Circulation. 2011 Dec 6;124(23):e574-651. doi: 10.1161/CIR.0b013e31823ba622. Epub 2011 Nov 7.
6
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.美国心脏协会/美国心脏病学会基金会关于冠状动脉及其他动脉粥样硬化性血管疾病患者二级预防和风险降低治疗的指南:2011年更新版
Circulation. 2011 Nov 29;124(22):2458-73. doi: 10.1161/CIR.0b013e318235eb4d. Epub 2011 Nov 3.
7
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials.血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂对血压正常的动脉粥样硬化患者有益:一项随机试验的荟萃分析。
Eur Heart J. 2012 Feb;33(4):505-14. doi: 10.1093/eurheartj/ehr400. Epub 2011 Oct 31.
8
Restenosis after PCI. Part 2: prevention and therapy.经皮冠状动脉介入治疗(PCI)后的再狭窄。第 2 部分:预防和治疗。
Nat Rev Cardiol. 2011 Oct 11;9(2):79-90. doi: 10.1038/nrcardio.2011.148.
9
Restenosis after PCI. Part 1: pathophysiology and risk factors.经皮冠状动脉介入治疗(PCI)后的再狭窄。第 1 部分:病理生理学和危险因素。
Nat Rev Cardiol. 2011 Sep 13;9(1):53-62. doi: 10.1038/nrcardio.2011.132.
10
Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial.药物洗脱支架与金属裸支架治疗隐静脉桥病变的比较(ISAR-CABG):一项随机对照优效性试验。
Lancet. 2011 Sep 17;378(9796):1071-8. doi: 10.1016/S0140-6736(11)61255-5. Epub 2011 Aug 26.